Vumerity and Breast cancer metastatic - a phase IV clinical study of FDA data

Summary:

Breast cancer metastatic is reported as a side effect among people who take Vumerity (diroximel fumarate), especially for people who are 50-59 old, have been taking the drug for 6 - 12 months also take Vitamin B12, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Breast cancer metastatic when taking Vumerity. It is created by eHealthMe based on reports of 9,775 people who have side effects when taking Vumerity from the FDA, and is updated regularly.

What is Vumerity?

Vumerity has active ingredients of diroximel fumarate. eHealthMe is studying from 9,781 Vumerity users. Check the latest studies of Vumerity.

What is Breast cancer metastatic?

Breast cancer metastatic is found to be associated with 600 drugs and 471 conditions by eHealthMe. Check the latest studies of Breast cancer metastatic.

On Jul, 29, 2026

9,775 people reported to have side effects when taking Vumerity.
Among them, 11 people (0.11%) have Breast cancer metastatic.

Could Vumerity cause Breast cancer metastatic?

Among these 11 people:

How long have people been on Vumerity when they have Breast cancer metastatic? *

What is the age of people who have Breast cancer metastatic when taking Vumerity? *

What are other drugs people take besides Vumerity? *

What are other side effects people have besides Breast cancer metastatic? *

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 18.18%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 9.09%
Pelvic Mass: 1 person, 9.09%
Pain In Extremity: 1 person, 9.09%
Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 9.09%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 9.09%
Inflammation: 1 person, 9.09%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 90.91%
Stress And Anxiety: 2 people, 18.18%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Vumerity and have Breast cancer metastatic?

- Check whether Breast cancer metastatic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vumerity:

Vumerity (9,781 reports)

Browse all side effects of Vumerity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast cancer metastatic:

Breast cancer metastatic (600 drugs)

Browse all the conditions that are associated with Breast cancer metastatic:

Breast cancer metastatic (471 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diroximel fumarate (the active ingredients of Vumerity) and Vumerity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.